EdmontonManufacturingAgriculture and FarmingBiotechnologyHealth CareMedicalCannabis
Description
Aurora Cannabis has acquired Internode Pharma Limited and HAP Pharma Limited to enhance its presence in the UK medical cannabis market. The acquisition, valued at GBP 2.1 million, allows Aurora to leverage its expertise and expand market share. This strategic move aims to ensure reliable supply for UK patients amidst growing demand. The transaction was completed through a wholly-owned subsidiary of Aurora.
Company Information
Company
Aurora Cannabis
Location
Edmonton, Alberta, Canada
About
The Company has granted the Underwriters an option, exercisable at the offering price for a period of 30 days following the closing of the Offering, to purchase up to an additional 15% of the Offering to cover over-allotments, if any. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable.
Don't miss Aurora Cannabis's next move
Get an email the moment Aurora Cannabis makes an acquisition, hires an exec, or expands, usually minutes after it happens.
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed
Frequently asked
Who acquired Internode Pharma Limited?
Internode Pharma Limited was acquired by Aurora Cannabis, based in Edmonton. The deal was reported on August 19, 2026. Aurora Cannabis is publicly traded (ACB) and operates in Manufacturing.
When did Aurora Cannabis acquire Internode Pharma Limited?
Aurora Cannabis's acquisition of Internode Pharma Limited was reported on August 19, 2026. Aurora Cannabis has acquired Internode Pharma Limited and HAP Pharma Limited to enhance its presence in the UK medical cannabis market. The acquisition, valued at GBP 2.1 million, allows Aurora to leverage its expertise and expand market share. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Internode Pharma Limited do?
Internode Pharma Limited is a licensed importer and wholesaler focused on medical cannabis products. The company aims to support the distribution of high-quality medical cannabis in international markets. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.